| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.33 | 5e-11 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.19 | 8e-09 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 3e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 7e-05 |